CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
Majbour, N. K.; Aasly, J. O.; Hustad, E.; Thomas, M. A.; Vaikath, N. N.; Elkum, N. & van de Berg, W. D. J. et al. (2020)
Translational Neurodegeneration, 9(1). DOI: https://doi.org/10.1186/s40035-020-00192-4
